PofoliaShared via Pofolia

Analytical Chemistry· 2026Q1

Rapid Species-Level Classification of Urinary Pathogens from Raw LC-MS/MS Signals Using Machine Learning

Shawn Pelletier, Antoine Lacombe-Rastoll, Florence Roux-Dalvai, Mickaël Leclercq et al.

Short summary

A machine learning model directly classifies urinary pathogen species from raw LC-MS/MS ion signals in ~5 minutes, achieving 91% accuracy on clinical samples with >10^5 CFU/mL and zero false positives on controls.

AI-generated from the title and abstract; the full text is not read.

Key points

  • A machine learning pipeline analyzes raw LC-MS/MS ion signals for direct microbial classification, bypassing peptide/protein identification.
  • The method achieves species-level identification in ~5 minutes post-preparation.
  • Achieved 91% accuracy on 206 clinical urine specimens with microbial loads >10^5 CFU/mL.
  • Demonstrated 0 false positives in control specimens.
  • Achieved a Matthews Correlation Coefficient (MCC) of 0.86 across 28 clinically relevant pathogens.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Urinary tract infections are among the most common infections in humans, yet their diagnosis still depends on time-consuming workflows based on microbial culture, followed by MALDI-TOF mass spectrometry. Although LC-MS/MS offers the sensitivity and specificity needed to bypass culture, conventional pipelines depend on lengthy analyses and peptide/protein identification steps, limiting the throughput and hindering its adoption in clinical settings. Here, we introduce a direct, identification-free LC-MS/MS workflow that analyzes raw ion signal and produces species-level microbial identification in about 5 min after preparation, fast enough to meet clinical throughput requirements. Our machine learning-enabled raw-signal pipeline bypasses peptide identification entirely, preserving information and eliminating the traditional interpretation stack. Across 15 independent analytical batches covering 28 clinically relevant pathogens, the method achieved high-confidence classification (MCC = 0.86). Applied to 206 clinical urine specimens across three batches, the approach reached 91% accuracy at clinically actionable microbial loads (greater than 105 CFU/mL) and, critically, 0 false positives in control specimens. The performance was lower for specimens below this threshold. These results show that raw LC-MS/MS spectra contain sufficient biological information for direct microbial diagnosis, establishing an analytical framework for clinical mass spectrometry. This proof-of-concept demonstrates that rapid, culture-free, fast microbial identification is achievable and positions raw signal inference as a promising direction for next-generation diagnostic mass spectrometry.

The authors' abstract, as published at the source. Analytical Chemistry, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Clinical Biochemistry

Clinical BiochemistryBiochemistry, Genetics and Molecular Biology